<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Natl Compr Canc Netw</journal-id><journal-id journal-id-type="iso-abbrev">J Natl Compr Canc Netw</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Journal of the National Comprehensive Cancer Network : JNCCN</journal-title></journal-title-group><issn pub-type="ppub">1540-1405</issn><issn pub-type="epub">1540-1413</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12211465</article-id><article-id pub-id-type="pmcid-ver">PMC12211465.1</article-id><article-id pub-id-type="pmcaid">12211465</article-id><article-id pub-id-type="pmcaiid">12211465</article-id><article-id pub-id-type="manuscript-id">NIHMS2081501</article-id><article-id pub-id-type="pmid">40341059</article-id><article-id pub-id-type="doi">10.6004/jnccn.2025.7007</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS2081501</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA2081501</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Trends in Prevalence and Correlates of Alcohol Use Disorder Diagnoses Among US Adult Cancer Survivors: Serial Cross-Sectional Analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Avance&#241;a</surname><given-names initials="ALV">Anton L.V.</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lai</surname><given-names initials="JH">Jyun-Heng</given-names></name><degrees>BPharm, MS</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Velasquez</surname><given-names initials="MM">Mary M.</given-names></name><degrees>PhD</degrees><xref rid="A3" ref-type="aff">3</xref><xref rid="A4" ref-type="aff">4</xref><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zigler</surname><given-names initials="CM">Corwin M.</given-names></name><degrees>PhD</degrees><xref rid="A6" ref-type="aff">6</xref><xref rid="A7" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Frei</surname><given-names initials="CR">Christopher R.</given-names></name><degrees>PharmD</degrees><xref rid="A8" ref-type="aff">8</xref><xref rid="A9" ref-type="aff">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pignone</surname><given-names initials="M">Michael</given-names></name><degrees>MD, MPH</degrees><xref rid="A10" ref-type="aff">10</xref><xref rid="A11" ref-type="aff">11</xref><xref rid="A12" ref-type="aff">12</xref></contrib></contrib-group><aff id="A1"><label>1</label> Health Outcomes Division, College of Pharmacy, The University of Texas at Austin, Austin, TX</aff><aff id="A2"><label>2</label> Department of Internal Medicine, Dell Medical School, The University of Texas at Austin, Austin, TX</aff><aff id="A3"><label>3</label> Health Behavior Research and Training Institute, Steve Hicks School of Social Work, The University of Texas at Austin, Austin, TX</aff><aff id="A4"><label>4</label> Department of Population Health, Dell Medical School, The University of Texas at Austin, Austin, TX</aff><aff id="A5"><label>5</label> Department of Psychiatry &amp; Behavioral Sciences, Dell Medical School, The University of Texas at Austin, Austin, TX</aff><aff id="A6"><label>6</label> Department of Statistics and Data Sciences, College of Natural Sciences, The University of Texas at Austin, Austin, TX</aff><aff id="A7"><label>7</label> Now with Department of Biostatistics, School of Public Health, Brown University, Providence, RI</aff><aff id="A8"><label>8</label> Pharmacotherapy and Translational Sciences Division, College of Pharmacy, The University of Texas at Austin, Austin, TX</aff><aff id="A9"><label>9</label> Pharmacotherapy Education and Research Center, Long School of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX</aff><aff id="A10"><label>10</label> Department of Medicine, Duke University School of Medicine, Durham, NC</aff><aff id="A11"><label>11</label> Duke Margolis Center for Health Policy, Duke University, Durham, NC</aff><aff id="A12"><label>12</label> Duke Cancer Institute, Duke University, Durham, NC.</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1"><bold>Author contributions:</bold>
<italic toggle="yes">Concept &amp; design:</italic> Avance&#241;a, Lai, Pignone. <italic toggle="yes">Acquisition, analysis, or interpretation of data:</italic> All authors. <italic toggle="yes">Statistical analysis:</italic> Avance&#241;a, Lai, Zigler. <italic toggle="yes">Funding acquisition:</italic> Avance&#241;a. <italic toggle="yes">Administrative, technical, or material support:</italic> Avance&#241;a, Lai, Pignone. <italic toggle="yes">Supervision:</italic> Velasquez, Zigler, Frei, Pignone. <italic toggle="yes">Writing</italic>&#8212;<italic toggle="yes">original draft:</italic> Avance&#241;a, Lai. <italic toggle="yes">Writing</italic>&#8212;<italic toggle="yes">review &amp; editing:</italic> All authors.</p></fn><corresp id="CR1"><bold>Correspondence:</bold> Anton L.V. Avance&#241;a, PhD, Health Outcomes Division, College of Pharmacy, The University of Texas at Austin, 2409 University Avenue, PHR 2.112, Austin, TX 78712. <email>antonlv@utexas.edu</email></corresp></author-notes><pub-date pub-type="ppub"><month>5</month><year>2025</year></pub-date><volume>23</volume><issue>5</issue><issue-id pub-id-type="pmc-issue-id">491856</issue-id><fpage>156</fpage><lpage>163</lpage><pub-history><event event-type="nihms-submitted"><date><day>16</day><month>06</month><year>2025</year></date></event><event event-type="pmc-release"><date><day>01</day><month>07</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>01</day><month>07</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-07-02 11:25:17.490"><day>02</day><month>07</month><year>2025</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-2081501.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P2">Alcohol use disorder (AUD) is associated with cancer recurrence, new malignancies, and mortality among survivors of certain cancers. This study evaluated trends (2012&#8211;2021) in prevalence and correlates of AUD diagnoses among adult cancer survivors in the United States.</p></sec><sec id="S2"><title>Methods:</title><p id="P3">This retrospective, serial cross-sectional study used claims data (2011&#8211;2021) from a national sample of US individuals with employer-sponsored health insurance. Adults diagnosed with malignant neoplasms who had at least 6 months of continuous health insurance enrollment prior to their cancer diagnosis were included. The primary outcome was a recent AUD diagnosis in each year of the study period identified from inpatient and outpatient records. We assessed AUD prevalence for each year among all cancer survivors and in specific subgroups. Using data from 2021, we compared sociodemographic and clinical characteristics between cancer survivors with and without AUD diagnoses and identified correlates of AUD diagnosis by using multivariable logistic regression.</p></sec><sec id="S3"><title>Results:</title><p id="P4">Of 5,956,137 eligible cancer survivors, 105,778 (1.78%) had received an AUD diagnosis. The annual prevalence of AUD diagnoses increased from 0.78% in 2012 to 1.43% in 2021 (<italic toggle="yes">P</italic>&lt;.0001). AUD prevalence also increased in specific subgroups, including individuals with alcohol-related cancers (from 0.88% to 1.61%; <italic toggle="yes">P</italic>&lt;.0001) and those receiving antineoplastic agents (from 0.97% to 1.60%; <italic toggle="yes">P</italic>&lt;.0001). Multivariable logistic regression analysis demonstrated that male sex, alcohol-related cancers, mental health diagnoses, and other substance use disorders were associated with at least 2 to 5 times greater odds of an AUD diagnosis.</p></sec><sec id="S4"><title>Conclusions:</title><p id="P5">AUD diagnosis among US cancer survivors with private health insurance has increased over time, mirroring trends in the general population. Integrating AUD screening and treatment into cancer care may help mitigate the unique risks associated with alcohol use and misuse in cancer survivors.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>